TCAF logo

TCAFT Rowe Price Capital Appreciation Equity ETF

$40.03
$0.89
(2.17%)
Today
Closed $40.03
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Vol753,432.00
52W High$41.19
52W Low$33.90
News
all
press releases
News Placeholder
BNTX Shares Rise On Goldman Sachs Upgrade, Optimism For Cancer Portfolio
Goldman raised the price target on BioNTech SE to $142, up from $115.
Stocktwits
News Placeholder
Why Did BioNTech Stock Surge 10% Pre-Market Today?
DualityBio now plans to discuss the next steps with the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China regarding the submission of an application for Trastuzumab Pamirtecan approval.
Stocktwits
News Placeholder
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing
The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.
Stocktwits
<
...
1
>

Advertisement|Remove ads.